SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMAT - ultrafast tomography for coronary artery disease

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: TA2K who wrote (3689)5/22/2001 2:47:43 PM
From: TA2K  Read Replies (1) of 3725
 
Classic Head and Shoulders

This is a good one to study.

See if you can spot the left shoulder, then the head, then the right shoulder. IMAT has penetrated below the 'neckline,' and is sliding down the arm.

There appears no TA reason why the slide won't continue for weeks to come. No reason to think there ought to be a basing pattern around $1.90.

IMAT could see a low around $1.75 within weeks.

And remember: Knuckle-headed CEO Lew Meyer changed his policy on issuing sales PRs, eliminating them entirely. So you shouldn't be expecting one of those to pop up and send IMAT up, like what always happened in the 'good old IMAT days.' Just have to wait until the end of the quarter to see how Imatron sales went --- that's another two months of waiting. Patiently???

Are you still tuned??
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext